← Open Payments lookup

MARK HAYGOOD: Open Payments

NPI 1073834370 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$103,698 in 260 payments from 17 companies in 2025. Trend: 2023 $50,751 · 2024 $45,587 · 2025 $103,698

Speaker / faculty: $83,992Travel & lodging: $7,544Consulting: $6,888Food & beverage: $5,275
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.97$85,750
ABBVIE INC.59$15,405
Axsome Therapeutics, Inc.18$583
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)15$435
Teva Pharmaceuticals USA, Inc.6$370
E.R. Squibb & Sons, L.L.C.18$313
Vanda Pharmaceuticals Inc.12$169
Otsuka America Pharmaceutical, Inc.9$163
Supernus Pharmaceuticals, Inc.7$132
Janssen Pharmaceuticals, Inc4$103

Products named: INGREZZA, VRAYLAR, Auvelity, CAPLYTA, AUSTEDO XR, COBENFY, REXULTI, FANAPT.

Industry payments across AL — which companies pay providers there.